BRIDGEBIO PHARMA, INC. (BBIO)
BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base
BridgeBio Pharma Announces Pricing of Oversubscribed Secondary Offering that Diversifies its Institutional Shareholder Base
Diginex Limited Announces Extraordinary General Meeting to Approve Proposed Acquisition of Resulticks
WRAP Selected by WOFT to Support Florida’s $475,000 Teacher Safety Training Initiative
Beneficient Reports First Quarter Fiscal 2027 Results
Super League Reports Second Quarter 2026 Financial Results, Highlighted by Improving Margins and Operating Performance
BTQ Technologies Provides Q2 2026 Corporate Update Highlighting Commercial Progress Across Trusted Quantum Technologies Platform
Lantern Pharma Reports Second Quarter 2026 Financial Results and Provides Business Update
IQST - IQSTEL to Host Q2 2026 Earnings Call August 19 Following Record $207 Million First-Half Revenue as Company Enters EBITDA Expansion Phase
Applied Materials to Participate in Upcoming Investor Conferences
U.S. Physical Therapy Announces CFO
Milestone Scientific Reports Financial Results for Second Quarter 2026
Boost Run Inc. Reports First Earnings as a Public Company, Reporting Second Quarter 2026 Results, Supported by $1.9 Billion Total Contract Value